Azithromycin vs Pembrolizumab

Azithromycin vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Azithromycin and Pembrolizumab.

Mechanism of Action

Azithromycin: Binds 50S ribosomal subunit, inhibiting bacterial protein synthesis.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Azithromycin — 68 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Azithromycin — C38H72N2O12.

Molecular Weight: Azithromycin — 748.9840 g/mol.

Type: Azithromycin — Small molecule; Pembrolizumab — Antibody.